Pfizer Incorporation Overview 

Pfizer Incorporation Overview 

An American pharmaceutical corporation established in the year 1849 with approximately 173 years in existence, Pfizer Inc is a leading company in the biotechnology industry whose dealings revolve around the production and sales of drugs and vaccines for a broad spectrum of biological areas. Pfizer Inc has several segments that help the corporation generate an accumulation of revenues amounting to a total sum of $1 Billion USD per year. Pfizer Inc has corporations scattered across the world in major countries such as China, Japan, United Kingdom, as well as other major countries in Europe. Pfizer Inc is ranked and rated highly by top-ranking agencies the likes of Forbes and Fortune. To be specific, research has sat that Pfizer Inc is ranked #49 on the Forbes Global 2000 list, as well as #64 on the Fortune 500, with the two rankings indicating the company is not only one of the largest corporations in the United States in terms of revenues but also, also amongst the companies with the largest revenue generation across the world. In this article, however, you will be shown a more detailed, comprehensive, and extensive review of Pfizer Inc. The kickoff will begin with the company’s key facts and it will flow to all aspects of its operations, and dealings. As such, all relevant information detailing its key facts, historical background, its divisions and segments, financial overview, as well as its pros and cons will be concisely covered to enable you to understand the significant and major elements of the pharmaceutical corporation as quickly as possible.        

Pfizer Inc Key Facts  

Founding Year: Pfizer Inc was founded in the year 1849, approximately 173 years ago.      

Industrial Ranking: Pfizer Inc is ranked and rated highly by top-ranking agencies the likes of Forbes and Fortune. To be specific, research has sat that Pfizer Inc is ranked #49 on the Forbes Global 2000 list, as well as #64 on the Fortune 500, with the two rankings indicating the company is not only one of the largest corporations in the United States in terms of revenues but also, also amongst the companies with the largest revenue generation across the world. 

Company Type: A Public Corporation Company (PLC)      

Market Reach:  Pfizer Inc operates globally, and has its offices mounted strategically in all major parts of the world. 

Industry Type: Pharmaceutical  

Trading Type:  Pfizer Inc is traded on the New York Stock Exchange (NYSE) market under the ticker symbol, PFE. The company’s stock is a component of the Russell 1000, as well the S&P 100 and S&P 500 respectively.    

Workforce Strength: Pfizer Inc has a total number of 79 000 employees in its workforce globally as of the 2021 report.      

Divisions: Pharmaceutical, Biotechnology, Animal Health 

Pfizer Inc  Historical Background 

 The pharmaceutical giant operating under the name, Pfizer Inc was founded by two immigrant cousins from Germany with the name, Charles Pfizer and Charles F. Erhart. The corporation as noted in the introductory section of this piece was founded in the year 1849, and its apex office is mounted on the street of Barlett  Williamsburgh, New York, United States. The corporation’s initial production was santonin and antiparasitic, however, when it launched the production of citric acid in the following year, the growth of the company was almost tripled by the product in the late 1880s. 

In the year 1881,  Pfizer Inc relocated its apex office to the new site in Manhattan. And in the following year which was 1882, the company expanded its operation to Chicago. And in the year 1906, Pfizer Inc recorded sales exceeding a total sum of $3 Million USD. 

In the 1950s, Pfizer Inc expanded rapidly as it extends to major countries of the world like Belgium, Mexico, Panama, Puerto Rico, the United Kingdom, as well as Canada, and Brazil. In the year 1952, Pfizer Inc launched its animal health division, which opened to run in Terre Haute, Indiana, with a landmass of 700-acre.  

By 1960, Pfizer Inc transited its medical facility out of the region of New York to a new site located in Groton Connecticut. And in the year 1980, Pfizer’s Feldene, was an anti-inflammatory drug. The release of the drug launched the company into recording its first $1 Billion USD in revenue generation. 

In the year 1972, the company’s board of directors appoints a new CEO in the person of Edmund T. Pratt Jr., who took the mantle of leadership from John Powers. Jr. 

The year 1989 witnessed the company acquiring global rights to Zithromax a drug recommended by the Infectious Disease Society of America to fight against the deadly disease known as pneumonia. 

In the year 1996, Pfizer Inc partnered with Eisai to receive the authorization from FDA to manufacture donepezil for the treatment of Alzheimer-related disease. The drug was to be produced under the brand name, Aricept. 

The year 1997 witnessed the company entering into an agreement with Warner-Lambart. And in the year 2002, Pfizer Inc stock was bought by one of the largest foundations in the world, The Bill & Melinda Gates Foundation. 

In the year 2004, Pfizer Inc got the authorization to manufacture an antidote that can be used to treat and cure diverse immune disorders and several neuropathic diseases such as epilepsy, neurosis, and fibromyalgia, amongst others. The name of the drug is to be called Lyrica. 

By December 3rd, 2006, Pfizer Inc cut the continual production of torcetrapib. Torcetrapib helps stimulates HDL which helps to reduce LDL an ailment related to heart disease. 

Pfizer Inc spent over $3 Million USD on several lawsuits and legal charges in a bid to kick against the counterfeit production and manufacturing of its drugs. During the fighting course, the company was able to lay got a sum of $5.1 Million as a prayer for relief while having another sum total of $5 Million USD from the same infringement course. 

In the year 20000, Pfizer Inc bought Warner-Lambert completely. The deal is worth a total sum of $116 Billion USD. In the year 200, Pfizer Inc was conjoined with Pharmacia and thereafter went ahead to buy SUGEN as well as Searle. 

In the year 2006, Pfizer Inc pronounced its intention to buy Powered. And in the year 2009, October 15 to be precise, the company bought Wyeth for a total sum of $68 Billion USD in both stock and cash. 

In the year 2010, Pfizer Inc’s board of directors appointed Ian Reed as the new CEO of the corporation. And in the year 2011, Pfizer Inc pronounced its intention to shut down its United Kingdom research and development office located on the coast of Sandwich, Kent with its total workforce amounting to an approximation of 2, 400 staff. In the same year, March, Pfizer Inc also bought a company operating under the name, King Pharmaceuticals for a total sum of $3.6 Billion USD (in cash only). 

By the year 2014, Pfizer Inc had already bought Innopharma, and in the year 2015, the company also bought Redvax, the purchase led to the expansion of the company’s vaccine segment. 

In the year 2021, Pfizer Inc bought stock in CStone Pharmaceuticals for the total sum of $200 Million USD. And in the year 2021, Pfizer Inc launched a new logo. In the same year, Pfizer Inc also bought Amphylx Pharmaceuticals as well as Fosmanogenix, its anti-fungi compound. 

And finally, in the year 2022, Pfizer Inc bought Biohaven Pharma as well as its related divisions in a deal amounting to a total sum of $11.6 Billion USD. By August, of the same year, in a bid to expand the company’s rare disease treatment enterprise, Pfizer Inc pronounced its intention to also purchase a company operating under the name, Global Blood Therapeutics. The deal was sealed with a total sum of $5.4 Billion USD, and as a result, the revenue of Pfizer Inc responded to the acquisition by increasing exponentially.      

      Pfizer Inc Business Divisions and Segments 

Pharmaceutical Drugs 

Vaccines 

Rare Disease  

Animal Health 

Biotechnological 

Health Research and Development 

Pfizer Inc Key Financials 

Revenues: $81. 29 Billion USD (2021) 

Operating Income: $224. 46 Billion USD (2021) 

Net Income: $21. 98 Billion USD (2021) 

Total Equity:  $77. 46 Billion USD (2021) 

Total Assets: 181.48 Billion USD (2021) 

Pros and Cons of Pfizer Inc. 

Pros 

Lengthy Industry Experience 

High-quality and Effective Products (Drugs, Vaccines, Medicines) 

Expertise 

Large Market Reach 

Reasonable and Fair Benefits for Employees 

Great People, Great Workplace  

Broad Spectrum of Product Portfolio 

Cons 

Poor Management 

Constant and Frequent Layoffs 

Relatively Low Career Progression 

Conclusion 

It has been in the industry for quite a long time, nonetheless, despite that, the corporation leverages its several acquisitions and corporation experience to increase its growth exponentially from its inception hitherto this day. The secret to this is, not quite far-fetched, it is, however, the company’s commitment to exceptional and innovative service offerings while helping customers and employees derive value in their respective pursuits. Finally, with all being said in the foregoing sections of this piece, I hope your expectation, as promised in the introductory part of this piece has been met, and that you have adequately absorbed all there is to know about this ever-expanding company, Pfizer Inc., and that the knowledge gained therein from this piece would help navigate your decision in the right direction.